Akumin Stock Forecast for 2023 - 2025 - 2030

Updated on 04/26/2024

Stock Rating
11
Price Target
$0.00
Consensus
-
Upside
44.74%
Analysts
0
Stock Rating
11
Upside
44.74%
Analysts
0
Price Target
$0.00
-

Akumin Fair Value Forecast for 2023 - 2025 - 2030

In the last three years, Akumin's Price has decreased from $0.19 to $0.00 – a 100.00% drop. In the next year, analysts believe that Fair Value will reach $0.00 – an increase of 100.00%. For the next six years, the forecast is for Fair Value to grow by 100.00%.

2025 Fair Value Forecast
$0.00
2026 Fair Value Forecast
$0.00
2027 Fair Value Forecast
$0.00
2028 Fair Value Forecast
$0.00
2029 Fair Value Forecast
$0.00
2030 Fair Value Forecast
$0.00
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
UHS Stock Forecast Universal Health Services Outperform 6
$166.06 Buy/Sell $162.38 13.81%
EHC Stock Forecast Encompass Health Buy 18
$82.47 Buy/Sell $85.22 15.19%
ACHC Stock Forecast Acadia Healthcare Company Outperform 15
$73.59 Buy/Sell $89.55 35.89%
SEM Stock Forecast Select Medical Holdings Outperform 16
$27.41 Buy/Sell $32.80 31.34%
SGRY Stock Forecast Surgery Partners Buy 13
$24.55 Buy/Sell $43.20 75.15%

Akumin Revenue Forecast for 2023 - 2025 - 2030

Akumin's Revenue has seen impressive growth In the last two years, rising from $246.08M to $749.63M – a growth of 204.63%. For the following year, the 0 analysts predict that Akumin's Revenue will drop by 43.07%, reaching $426.74M. In 2030, the professionals' prediction is that AKUM.Q's Revenue will decrease by 32.23%, reaching $508.00M.

2023 Rev Forecast
$0.43B
2024 Rev Forecast
$0.41B
2025 Rev Forecast
$0.46B
2026 Rev Forecast
$0.57B
2027 Rev Forecast
$0.52B
2028 Rev Forecast
$0.48B
2029 Rev Forecast
$0.48B
2030 Rev Forecast
$0.51B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
RDNT Stock Forecast RadNet Outperform 15
$48.40 Buy/Sell $40.20 8.47%
CYH Stock Forecast Community Health Systems Outperform 11
$3.39 Buy/Sell $4.98 21.83%
SSY Stock Forecast SunLink Health Systems - 0
$0.90 Buy/Sell $0.00 -100.00%

Akumin Dividend per Share Forecast for 2023 - 2025 - 2030

Akumin Free Cash Flow Forecast for 2023 - 2025 - 2030

Akumin EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, Akumin's EBITDA has seen an increase, rising from $46.16M to $145.70M. This represents a growth of 215.64%. According to the 0 analysts polled, in the next year, Akumin's EBITDA will fall by 46.93%, reaching $77.32M. By 2030, professionals believe that Akumin's EBITDA will have decreased by 33.79%, falling to $96.47M.

2023 EBITDA Forecast
$0.08B
2024 EBITDA Forecast
$0.08B
2025 EBITDA Forecast
$0.09B
2026 EBITDA Forecast
$0.11B
2027 EBITDA Forecast
$0.10B
2028 EBITDA Forecast
$0.09B
2029 EBITDA Forecast
$0.09B
2030 EBITDA Forecast
$0.10B

Akumin EBIT Forecast for 2023 - 2025 - 2030

Akumin's EBIT has seen growth In the last two years, going from $25.74M to $47.49M – a gain of 84.50% For the next year, 0 analysts project Akumin's EBIT to drop by 18.52%, reaching $38.70M. By 2030, professionals believe that Akumin's EBIT will decrease by 17.57%, reaching $39.15M – a concerning trend for the company.

2023 EBIT Forecast
$0.04B
2024 EBIT Forecast
$0.04B
2025 EBIT Forecast
$0.03B
2026 EBIT Forecast
$0.04B
2027 EBIT Forecast
$0.04B
2028 EBIT Forecast
$0.04B
2029 EBIT Forecast
$0.04B
2030 EBIT Forecast
$0.04B

Akumin EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last three years, Akumin's EPS has decreased from $0.01 to $0.00 – a 100.00% drop. In the next year, analysts believe that EPS will reach $0.00 – an increase of 100.00%. For the next six years, the forecast is for EPS to grow by 100.00%.

2025 EPS Forecast
$0.00
2026 EPS Forecast
$0.00
2027 EPS Forecast
$0.00
2028 EPS Forecast
$0.00
2029 EPS Forecast
$0.00
2030 EPS Forecast
$0.00